The in vitro plasma distribution of a novel cholesteryl ester transfer protein inhibitor, torcetrapib, is influenced by differences in plasma lipid concentrations

Pharmaceutical Research

Volumn 23, Issue 5, 2006, Pages 1025-1030

  Lee, S D ^a   Wasan, K M ^a   Calcagni, A ^b   Avery, M ^b   McCush, F ^b   Chen, C ^b,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^c SCIOS INC   (United States)

Author keywords

CP 529,414; Distribution; Lipid profile; Plasma lipoproteins; Torcetrapib

Indexed keywords

ANTICHOLESTEREMIC AGENTS; CHOLESTEROL ESTER TRANSFER PROTEINS; HUMANS; LIPIDS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; PROTEIN BINDING; QUINOLINES; TRIGLYCERIDES;

EID: 33646882593     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-006-9908-2     Document Type: Article

References (21)

1. K. M. Wasan S. M. Cassidy 1998 Modifications in plasma lipoprotein concentration and lipid composition regulate the biological activity of hydrophobic drugs J. Pharm. Sci. 87 411 424
2. C. B. Hesler A. R. Tall T. L. Swenson P. K. Weech Y. L. Marcel R. W. Milne 1988 Monoclonal antibodies to the Mr 74,000 cholesteryl ester transfer protein neutralize all of the cholesteryl ester and triglyceride transfer activities in human plasma J. Biol. Chem. 263 11 5020 5023
3. A. R. Tall 1993 Plasma cholesteryl ester transfer protein J. Lipid Res. 34 1255 1274
4. Y. C. Ha P. J. Barter 1982 Differences in plasma cholesteryl ester transfer activity in sixteen vertebrate species Comp. Biochem. Physiol. B. 71 2 265 269
5. P. Moulin 1996 Cholesteryl ester transfer protein: an enigmatic protein Horm. Res. 45 3-5 238 244
6. A. R. Tall E. Abreu J. Shuman 1983 Separation of a plasma phospholipid transfer protein from cholesterol ester/phospholipid exchange protein J. Biol. Chem. 258 4 2174 2180
7. R. E. Morton D. B. Zilversmit 1982 Purification and characterization of lipid transfer protein(s) from human lipoprotein-deficient plasma J. Lipid Res. 23 7 1058 1067
8. A. R. Tall 1995 Plasma cholesteryl ester transfer protein and high-density lipoproteins: new insights from molecular genetic studies J. Intern. Med. 7 1 5 12
9. P. J. Barter B. B. Brewer M. J. Chapman C. H. Hennekens D. J. Rader A. R. Tall 2003 Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis Arterioscler. Thromb. Vasc. BioI. 23 2 160 167
10. M. E. Brousseau M. R. Diffenderfer J. S. Millar C. Nartsupha B. F. Asztalos F. K. Welty M. L. Wolfe M. Rudling I. Bjorkhem B. Angelin J. P. Mancuso A. G. Digenio D. J. Rader E. J. Schaefer 2005 Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism and fecal sterol excretion Arterioscler. Thromb. Vasc. Biol. 25 5 1057 1064
11. M. E. Brousseau, E. J. Schaefer, M. L. Wolfe, L. T. Bloedon, A. G. Digenio, R. W. Clark, J. P. Mancuso, and D. J. Rader. Effects of an inhibitor of cholesteryl ester transfer protein on HDL Cholesterol. N. Engl. J. Med. 350(15):1505-1515.
12. K. Maeda H. Okamoto H. Shinkai 2004 S-(2-(Acylamino)phenyl) 2,2-dimethylpropanethioates as CETP inhibitors Bioorg. Med. Chem. Lett. 14 10 2589 2591
13. R. W. Clark T. A. Sutfin R. B. Ruggeri A. T. Willauer E. D. Sugarman G. Magnus-Aryitey P. G. Cosgrove T. M. Sand R. T. Wester J. A. Williams M. E. Perlman M. J. Bamberger 2004 Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of Torcetrapib Arterioscler. Thromb. Vasc. Biol. 24 3 490 497
14. D. B. Lloyd M. E. Lira L. S. Wood L. K. Durham T. B. Freeman G. M. Preston X. Qiu E. Sugarman P. Bonnette A. Lanzetti P. M. Milos J. F. Thompson 2005 Cholesteryl ester transfer protein variants have differential stability but uniform inhibition by Torcetrapib J. Biol. Chem. 280 15 14918 14922
15. H. Okamoto F. Yonemori K. Wakitani T. Minow K. Maeda H. Shinkai 2000 A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits Nature 406 6792 203 207
16. H. V. Kothari K. J. Poirier W. H. Lee Y. Satoh 1997 Inhibition of cholesteryl ester transfer protein by GGS 25159 and changes in lipoproteins in hamsters Atherosclerosis 128 1 59 66
17. G. J. de Grooth J. A. Kuivenhoven A. F. H. Stalenhoef J. de Graaf A. H. Zinderman J. L. Posma A. van Tol J. J. P. Kastelein 2002 Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study Circulation 105 18 2159 2165
18. K. M. Wasan P. H. Pritchard M. Ramaswamy W. Wong E. M. Donnachie L. J. Brunner 1997 Differences in lipoprotein lipid concentration and composition modify the plasma distribution of cyclosporine Pharm. Res. 14 11 1613 1620
19. D. P. Rossignol K. M. Wasan E. Choo E. Yau N. Wong J. Rose J. Moran M. Lynn 2004 Antimicrob. Agents Chemother. 48 9 3233 3240
20. R. M. Procyshyn N. B. Kennedy S. Marriage K. M. Wasan 2001 Plasma protein and lipoprotein distribution of clozapine Am. J. Psychiatry 158 6 949 951
21. N. S. Chung K. M. Wasan 2004 Potential role of the low-density lipoprotein receptor family as mediators of cellular drug uptake Adv. Drug Deliv. Rev. 56 9 1315 1334